12.07.2015 Views

BP Annual Report and Form 20-F 2011 - Company Reporting

BP Annual Report and Form 20-F 2011 - Company Reporting

BP Annual Report and Form 20-F 2011 - Company Reporting

SHOW MORE
SHOW LESS
  • No tags were found...

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Directors’ remuneration reportShare plans in detailPerformance share element of EDIP (audited)PerformanceperiodDate ofaward ofperformancesharesShare element interests Interests vested in <strong>20</strong>11 <strong>and</strong> <strong>20</strong>12Potential maximum performance shares aNumber ofMarket priceordinaryof each shareAt 1 Jan Awarded At 31 DecsharesVesting at vesting<strong>20</strong>11<strong>20</strong>11<strong>20</strong>11vested bdate£R W Dudley c <strong>20</strong>09-<strong>20</strong>11 06 May <strong>20</strong>09 539,634 – 539,634 101,735 15 Feb <strong>20</strong>12 4.98<strong>20</strong>10-<strong>20</strong>12 09 Feb <strong>20</strong>10 581,082 – 581,082 – – –<strong>20</strong>11-<strong>20</strong>13 09 Mar <strong>20</strong>11 d – 1,330,332 1,330,332 – – –I C Conn <strong>20</strong>08-<strong>20</strong>10 13 Feb <strong>20</strong>08 578,376 – – 0 – –<strong>20</strong>08-<strong>20</strong>11 e 13 Feb <strong>20</strong>08 133,452 – – 155,695 22 Feb <strong>20</strong>11 4.91<strong>20</strong>08-<strong>20</strong>13 e 13 Feb <strong>20</strong>08 133,452 – 133,452 – – –<strong>20</strong>09-<strong>20</strong>11 11 Feb <strong>20</strong>09 780,816 – 780,816 149,259 15 Feb <strong>20</strong>12 4.98<strong>20</strong>10-<strong>20</strong>12 09 Feb <strong>20</strong>10 656,813 – 656,813 – – –<strong>20</strong>11-<strong>20</strong>13 09 Mar <strong>20</strong>11 d – 623,025 623,025 – – –Dr B E Grote c <strong>20</strong>08-<strong>20</strong>10 13 Feb <strong>20</strong>08 581,748 – – 0 – –<strong>20</strong>09-<strong>20</strong>11 11 Feb <strong>20</strong>09 992,928 – 992,928 187,193 15 Feb <strong>20</strong>12 4.98<strong>20</strong>10-<strong>20</strong>12 09 Feb <strong>20</strong>10 801,894 – 801,894 – – –<strong>20</strong>11-<strong>20</strong>13 09 Mar <strong>20</strong>11 d – 785,394 785,394 – – –<strong>Form</strong>er directorsDr A B Hayward <strong>20</strong>08-<strong>20</strong>10 13 Feb <strong>20</strong>08 845,319 – – 0 – –<strong>20</strong>09-<strong>20</strong>11 11 Feb <strong>20</strong>09 755,512 – 755,512 f 144,422 15 Feb <strong>20</strong>12 4.98<strong>20</strong>10-<strong>20</strong>12 09 Feb <strong>20</strong>10 303,948 – 303,948 f – – –A G Inglis <strong>20</strong>08-<strong>20</strong>10 13 Feb <strong>20</strong>08 578,376 – – 0 – –<strong>20</strong>09-<strong>20</strong>11 11 Feb <strong>20</strong>09 5<strong>20</strong>,544 – 5<strong>20</strong>,544 f 99,506 15 Feb <strong>20</strong>12 4.98<strong>20</strong>10-<strong>20</strong>12 09 Feb <strong>20</strong>10 218,938 – 218,938 f – – –a<strong>BP</strong>’s performance is measured against the oil sector. For awards under the <strong>20</strong>09-<strong>20</strong>11 plan, performance conditions are measured 50% on TSR against ExxonMobil, Shell, Total, ConocoPhillips <strong>and</strong>Chevron <strong>and</strong> 50% on a balanced scorecard of underlying performance. For the awards under the <strong>20</strong>10-<strong>20</strong>12 plan, performance conditions are measured one third on TSR against ExxonMobil, Shell, Total,ConocoPhillips <strong>and</strong> Chevron <strong>and</strong> two thirds on a balanced scorecard of underlying performance. For awards under <strong>20</strong>11-<strong>20</strong>13 plan, performance conditions are measured 50% on TSR against ExxonMobil,Shell, Total, ConocoPhillips <strong>and</strong> Chevron; <strong>20</strong>% on reserves replacement against the same peer group; <strong>and</strong> 30% against a balanced scorecard of strategic imperatives. Each performance period ends on31 December of the third year.bRepresents vestings of shares made at the end of the relevant performance period based on performance achieved under rules of the plan <strong>and</strong> includes re-invested dividends on the shares vested.cDr Grote <strong>and</strong> Mr Dudley receive awards in the form of ADSs. The above numbers reflect calculated equivalents in ordinary shares.dThe market price of ordinary shares on 9 March <strong>20</strong>11 was £4.85 <strong>and</strong> for ADSs was $47.41.eRestricted award under share element of EDIP. As reported in the <strong>20</strong>07 directors’ remuneration report in February <strong>20</strong>08, the committee awarded Mr Conn restricted shares, as set out above <strong>and</strong> includesre-invested dividends on the shares vested. The remaining award vests on the fifth anniversary of the award, dependent on the remuneration committee being satisfied as to their personal performance atthe date of vesting. Any unvested tranche will lapse in the event of cessation of employment with the company.fPotential maximum of performance shares reflect actual service during performance period on a pro-rated basis.Directors’ remuneration reportshares aDeferred share element of EDIP (audited)Deferred share element interests Interests vested in <strong>20</strong>10 <strong>and</strong> <strong>20</strong>11NameyearTypeperiod<strong>20</strong>11 <strong>20</strong>11 <strong>20</strong>11 vesteddate£Date of awardPotential maximum deferred shares Number ofordinaryMarket priceof each shareBonusPerformanceof deferred At 1 Jan Awarded At 31 Dec shares Vesting at vestingI C Conn <strong>20</strong>10 Compulsory <strong>20</strong>11-<strong>20</strong>13 09 Mar <strong>20</strong>11 – 21,384 21,384 – – –Voluntary <strong>20</strong>11-<strong>20</strong>13 09 Mar <strong>20</strong>11 – – – – – –Matching <strong>20</strong>11-<strong>20</strong>13 09 Mar <strong>20</strong>11 – 21,384 21,384 – – –Dr B E Grote b <strong>20</strong>10 Compulsory <strong>20</strong>11-<strong>20</strong>13 09 Mar <strong>20</strong>11 – 26,604 26,604 – – –Voluntary <strong>20</strong>11-<strong>20</strong>13 09 Mar <strong>20</strong>11 – 26,604 26,604 – – –Matching <strong>20</strong>11-<strong>20</strong>13 09 Mar <strong>20</strong>11 – 53,<strong>20</strong>8 53,<strong>20</strong>8 – – –aThe market price of ordinary shares on 9 March <strong>20</strong>11 was £4.85 <strong>and</strong> for ADSs was $47.41.bDr Grote received awards in the form of ADSs. The above numbers reflect calculated equivalents in ordinary shares.<strong>BP</strong> <strong>Annual</strong> <strong>Report</strong> <strong>and</strong> <strong>Form</strong> <strong>20</strong>-F <strong>20</strong>11 149

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!